American Century Companies

American Century Companies Portfolio holdings

AUM $197B
1-Year Est. Return 27.8%
 

American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.

This Quarter Est. Return
1 Year Est. Return
+27.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$197B
AUM Growth
+$12.5B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,975
New
Increased
Reduced
Closed

Top Buys

1 +$1.13B
2 +$332M
3 +$296M
4
TSM icon
TSMC
TSM
+$182M
5
PCAR icon
PACCAR
PCAR
+$175M

Top Sells

1 +$419M
2 +$403M
3 +$350M
4
AMAT icon
Applied Materials
AMAT
+$259M
5
NSC icon
Norfolk Southern
NSC
+$256M

Sector Composition

1 Technology 27.77%
2 Financials 13.55%
3 Consumer Discretionary 12.64%
4 Industrials 9.69%
5 Communication Services 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERV
2776
DELISTED
Verve Therapeutics
VERV
-169,168
ANSS
2777
DELISTED
Ansys
ANSS
-5,279
AORT icon
2778
Artivion
AORT
$2.1B
-6,460
NOTV icon
2779
Inotiv
NOTV
$19M
-41,933
SABR icon
2780
Sabre
SABR
$525M
-127,684
SAGE
2781
DELISTED
Sage Therapeutics
SAGE
-141,828
SHYF
2782
DELISTED
The Shyft Group
SHYF
-73,456
SKX
2783
DELISTED
Skechers
SKX
-70,650
SON icon
2784
Sonoco
SON
$4.76B
-40,350
SPRY icon
2785
ARS Pharmaceuticals
SPRY
$1.03B
-21,114
SPTN
2786
DELISTED
SpartanNash
SPTN
-1,280,746
SSBK
2787
DELISTED
Southern States Bancshares
SSBK
-42,827
STR
2788
DELISTED
Sitio Royalties
STR
-58,256
SWTX
2789
DELISTED
SpringWorks Therapeutics
SWTX
-4,907
THRD
2790
DELISTED
Third Harmonic Bio
THRD
-34,299
UNIT
2791
Uniti Group
UNIT
$1.85B
-12,882
BRFS
2792
DELISTED
BRF SA
BRFS
-1,347,502
EVRI
2793
DELISTED
Everi Holdings
EVRI
-149,360
GNE icon
2794
Genie Energy
GNE
$384M
-21,862
GTLS.PRB
2795
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
-15,679
GYRE icon
2796
Gyre Therapeutics
GYRE
$800M
-11,291
ACA icon
2797
Arcosa
ACA
$5.75B
-12,690
ADVM
2798
DELISTED
Adverum Biotechnologies
ADVM
-10,670
AEVA
2799
Aeva Technologies
AEVA
$1.09B
-44,357
AGL icon
2800
Agilon Health
AGL
$395M
-488,153